Motley Fool Australia
  •  

    Notifications

    Scott

    Wondering where you should invest $1,000 right now?

    Scott Phillips just released his 5 best stocks to buy right now and you could grab the names of these stocks instantly!

    Learn More
  • Log Out
  • Menu
  1. Stocks
    2. /
  2. Clarity Pharmaceuticals Ltd (ASX: CU6)
    3. /

Clarity Pharmaceuticals Ltd (ASX: CU6) Share Price and News

Price

$2.08

Movement

0.12 (-5.46%)

As at 20 Jun - Closed (20 mins delayed)

52 Week Range

$1.43 - $8.975

 
1 Year Return

-57.11%

Clarity Pharmaceuticals Ltd Chart and Price Data

2025
2025
2025
2025
$0
$5
$10
$0
$5
$10
$0
$5
$10
$0
$5
$10

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $668.41 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 321.35 million
Earnings per share -0.163
Dividend per share N/A
Year To Date Return -50.12%
Earnings Yield N/A
Franking -
Earnings Yield

N/A

Franking

-

Dividend per share

N/A

Year To Date Return

-50.12%

Shares Outstanding

321.35 million

Earnings per share

-0.163

Share Price

$2.08

Day Change

0.12 (-5.46%)

52 Week Range

$1.43 - $8.975

Yesterday's Close

$2.20

Today's Open

$2.21

Days Range

$2.01 - $2.235

Volume

6,372,811

Avg. Volume (1 month)

2,884,123

Turnover

$13,252,699

As at 20 Jun - Closed

    • Clarity Pharmaceuticals Ltd (ASX: CU6)
    Latest News

    Man looking happy and excited as he looks at his mobile phone.
    Share Gainers

    Why Champion Iron, Clarity Pharmaceuticals, St Barbara, and Woodside shares are charging higher today

    | James Mickleboro

    These shares are having a good session today. But why are investors buying them?

    Read more »

    A woman jumps for joy with a rocket drawn on the wall behind her.
    Healthcare Shares

    Guess which ASX 200 stock is jumping 10% on big news

    | James Mickleboro

    This stock is catching the eye with a strong gain on Thursday. But why?

    Read more »

    A woman's hand draws a stylised 'Top Ten' on a projected surface.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    ASX shares returned to positive territory this Tuesday.

    Read more »

    Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
    Share Gainers

    Why Breville, Clarity, EOS, and TechnologyOne shares are racing higher today

    | James Mickleboro

    These shares are having a strong session on Tuesday. But why?

    Read more »

    A group of medical researchers stands side by side with each other wearing white coats in their research laboratory with scientific equipment in the background.
    Healthcare Shares

    Trump executive order to hit these 3 ASX pharmaceutical stocks

    | Samantha Menzies

    Donald Trump’s new executive order caused these 3 ASX pharmaceutical stocks to crash on Monday.

    Read more »

    A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    ASX investors were in the mood for buying this Tuesday.

    Read more »

    Person pretends to types on laptop drawn in sand.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a happy finish to the week for ASX shares this Friday.

    Read more »

    Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was the ASX's fourth day of gains for the week today.

    Read more »

    Ten happy friends leaping in the air outdoors.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a great end to the week's trading today...

    Read more »

    Man on computer looking at graphs
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    Investors were back to the races this hump day...

    Read more »

    Small chocolate bunnies.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    Investors ended the short trading week on a high today.

    Read more »

    Ecstatic man giving a fist pump in an office hallway.
    Share Gainers

    Why Brainchip, Challenger, Clarity, and Gorilla Gold Mines shares are storming higher

    | James Mickleboro

    These shares are rising more than most on Thursday. But why?

    Read more »

    CU6 ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    17th Jun 2025 2025-06-17T09:36:29 Clarity enters a Commercial Manufacturing AgreementYesNo9:36am4326k
    13th Jun 2025 2025-06-13T09:58:02 SABRE topline resultsYesNo9:58am6402k
    5th Jun 2025 2025-06-05T09:49:22 DISCO topline resultsYesNo9:49am6382k
    5th Jun 2025 2025-06-05T08:22:46 Ceasing to be a substantial holderYesNo8:22am3256k
    30th May 2025 2025-05-30T11:08:13 Notification regarding unquoted securities - CU6YesNo11:08am616k
    29th May 2025 2025-05-29T09:34:00 First patient imaged in Phase III AMPLIFY trialYesNo9:34am4336k
    20th May 2025 2025-05-20T09:55:45 AMPLIFY trial commencesYesNo9:55am4341k
    15th May 2025 2025-05-15T16:24:02 Ceasing to be a substantial holderYesNo4:24pm5452k
    13th May 2025 2025-05-13T15:43:51 Becoming a substantial holderYesNo3:43pm27393k
    2nd May 2025 2025-05-02T08:26:11 Change in substantial holdingYesNo8:26am261.5M

    About Clarity Pharmaceuticals Ltd

    Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.

    CU6 Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 Jun 2025 $2.08 $-0.12 -5.45% 6,372,811 $2.21 $2.24 $2.01
    19 Jun 2025 $2.20 $0.02 0.92% 3,150,362 $2.18 $2.32 $2.17
    18 Jun 2025 $2.18 $-0.06 -2.68% 1,726,012 $2.24 $2.28 $2.17
    17 Jun 2025 $2.24 $0.01 0.45% 2,748,748 $2.30 $2.37 $2.21
    16 Jun 2025 $2.23 $0.07 3.24% 1,905,612 $2.15 $2.29 $2.13
    13 Jun 2025 $2.16 $-0.18 -7.69% 3,129,929 $2.37 $2.45 $2.15
    12 Jun 2025 $2.34 $0.11 4.93% 1,668,330 $2.23 $2.38 $2.23
    11 Jun 2025 $2.23 $-0.16 -6.69% 3,737,100 $2.43 $2.43 $2.17
    10 Jun 2025 $2.39 $0.14 6.22% 2,001,966 $2.30 $2.43 $2.27
    06 Jun 2025 $2.25 $-0.08 -3.43% 2,426,296 $2.32 $2.41 $2.23
    05 Jun 2025 $2.33 $0.25 12.02% 4,510,379 $2.24 $2.35 $2.11
    04 Jun 2025 $2.08 $0.08 4.00% 1,783,034 $2.03 $2.11 $2.02
    03 Jun 2025 $2.00 $0.11 5.80% 2,844,113 $1.91 $2.02 $1.86
    02 Jun 2025 $1.90 $-0.27 -12.50% 4,959,828 $2.12 $2.12 $1.84
    30 May 2025 $2.16 $0.00 0.00% 12,178,171 $2.15 $2.19 $2.09
    29 May 2025 $2.16 $0.01 0.47% 4,123,158 $2.20 $2.37 $2.12
    28 May 2025 $2.15 $-0.06 -2.71% 1,892,186 $2.28 $2.30 $2.09
    27 May 2025 $2.21 $0.00 0.00% 913,951 $2.24 $2.26 $2.16
    26 May 2025 $2.21 $0.01 0.45% 1,036,820 $2.20 $2.28 $2.16
    23 May 2025 $2.20 $-0.09 -3.93% 989,894 $2.26 $2.29 $2.19
    22 May 2025 $2.29 $-0.03 -1.29% 949,564 $2.27 $2.30 $2.22

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    20 Nov 2024 Thomas Ramdahl Issued 17,080 $93,018
    Issue of options. Indicative value of $93,018 using a BlackScholes valuation using the 5-day VWAP
    20 Nov 2024 Christopher Roberts Issued 17,080 $93,018
    Issue of options. Indicative value, BlackScholes valuation using the 5-day VWAP
    20 Nov 2024 Alan Taylor Issued 740,748 $2,041,200
    Issue of options. Black-Scholes
    valuation, Monte Carlo
    simulation , Indicative value, VWAP
    20 Nov 2024 Rosanne Robinson Issued 17,080 $93,018
    Issue of options. Indicative value of $93,018 using a BlackScholes valuation using the 5-day VWAP
    20 Nov 2024 Michelle Parker Issued 172,356 $613,750
    Issue of options. Black-Scholes valuation, Monte Carlo simulation, vwap, Indicative value
    20 Nov 2024 Colin Biggin Issued 285,918 $787,875
    Issue of options. Black-Scholes
    valuation, Monte Carlo
    simulation , Indicative value, VWAP
    02 Oct 2024 Michelle Parker Buy 542,710 $495,000
    Exercise of options. vwap
    02 Oct 2024 Michelle Parker Exercise 600,000 $495,000
    Exercise of options. vwap
    01 Oct 2024 Colin Biggin Exercise 1,200,000 $990,000
    Exercise of options. VWAP
    01 Oct 2024 Alan Taylor Exercise 1,200,000 $990,000
    Exercise of options. VWAP
    01 Oct 2024 Colin Biggin Buy 1,084,321 $990,000
    Exercise of options. VWAP
    01 Oct 2024 Alan Taylor Buy 1,083,776 $990,000
    Exercise of options. VWAP
    01 Oct 2024 Christopher Roberts Exercise 200,000 $165,000
    Exercise of options. VWAP
    01 Oct 2024 Thomas Ramdahl Buy 200,000 $165,000
    Exercise of options. vwap
    01 Oct 2024 Christopher Roberts Buy 200,000 $165,000
    Exercise of options. VWAP
    01 Oct 2024 Thomas Ramdahl Exercise 200,000 $165,000
    Exercise of options. vwap
    17 Sep 2024 Rosanne Robinson Exercise 200,000 $165,000
    Exercise of options.
    17 Sep 2024 Rosanne Robinson Buy 178,079 $165,000
    Exercise of options.
    07 Aug 2024 Colin Biggin Buy 905,625 $605,000
    Exercise of options. vwap
    07 Aug 2024 Colin Biggin Exercise 1,000,000 $605,000
    Exercise of options. vwap
    01 Aug 2024 Colin Biggin Buy 542,835 $363,000
    Exercise of options. VWAP
    01 Aug 2024 Colin Biggin Exercise 600,000 $363,000
    Exercise of options. VWAP
    01 Aug 2024 Alan Taylor Buy 543,002 $363,000
    Exercise of options.
    01 Aug 2024 Alan Taylor Exercise 600,000 $363,000
    Exercise of options.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Christopher Graham Roberts Non-Executive Director Mar 2016
    Dr Roberts has over 40 years of experience in the medical innovation space and has served on the boards of a number of ASX-listed companies during his career. He is member of Risk Committee.
    Ms Rosanne Elizabeth Robinson Lead Independent DirectorNon-Executive Director Oct 2010
    Ms Robinson brings experience in the nuclear field and a range of commercial and operational expertise to the Group. She has over 25 years of experience in senior leadership and governance roles in public and private companies and government. She is member of Risk Committee.
    Dr Alan John Taylor Executive ChairmanExecutive Director Nov 2013
    Dr Taylor has over 15 years of investment banking experience focused predominantly on the life sciences sector, and has significant expertise in capital raisings, mergers and acquisitions, and general corporate advisory.
    Dr Colin David Biggin Chief Executive OfficerManaging Director Oct 2019
    Dr Biggin has over 15 years of radiopharmaceutical development and commercialisation experience. Dr Biggin previously served with Algeta ASA during the development and commercialisation of its product Xofigo for metastatic prostate cancer, which was approved by the US FDA in 2013. Prior to joining the Company, Dr Biggin also consulted to a range of biotech and large pharmaceutical companies developing radiopharmaceuticals.
    Ms Michelle Parker Executive Director Sep 2024
    Ms Parker has over 20 years of experience spanning nuclear medicine, positron emission tomography and pharmaceuticals in Australia and internationally. Prior to joining Clarity, Ms Parker held the position of Head of International Clinical Research Operations at Novartis Australia
    Mr Robert Cochrane Vickery Chief Financial OfficerCompany Secretary
    -
    David Green Chief Financial Officer
    -
    Robert Cochrane Vickery Chief Financial OfficerCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Citicorp Nominees Pty Limited 22,818,280 7.23%
    UBS Nominees Pty Ltd 19,336,534 6.12%
    Cabbit Pty Ltd Atf Robwill Trust 17,911,280 5.67%
    J P Morgan Nominees Australia Pty Limited 16,935,337 5.36%
    T M Ventures Pty Ltd 16,699,842 5.29%
    HSBC Custody Nominees (Australia) Limited 14,248,257 4.51%
    A.C.N. 136 437 913 Pty Ltd Atf The Taylor Family A/C 13,266,660 4.20%
    Argo Investments Limited 9,802,322 3.10%
    Yarrawah Pty Ltd Atf Peter Henderson P/L S/F A/C 8,040,000 2.55%
    Vantres Pty Ltd Atf Asten Super Fund A/C 6,812,340 2.16%
    Boorris Pty Ltd Atf Boorris Trust 6,065,800 1.92%
    BNP Paribas Noms Pty Ltd 5,356,049 1.70%
    Pacific Custodians Pty Limited 5,280,485 1.67%
    Smarter Capital Pty Ltd 5,004,543 1.58%
    National Nominees Limited 4,438,511 1.41%
    Kylaco Pty Ltd 3,896,280 1.23%
    Bnp Paribas Nominees Pty Ltd 3,713,550 1.18%
    Australian Nuclear Science & Technology Organisation 3,599,920 1.14%
    Colin Biggin 3,249,764 1.03%
    Wyargine Holdings Pty Ltd Atf Shellcove Super Fund 3,210,425 1.02%

    Profile

    since

    Note